Summary
Cerus Corp (Cerus) is a biomedical products manufacturing company which develops and commercializes Intercept Blood System for blood safety. The company has rights of Intercept for three blood components, namely, platelets, red blood cells and plasma. The system is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells (WBC) included in donated blood components intended for transfusion. It markets its product in the US, Europe, Russia, the Middle East and selected countries of other regions of the world for the treatment of both platelets and plasma for transfusions and it is also being developed for the treatment of red blood cells. Cerus is headquartered in Concord, California, the US.
Cerus Corp (CERS) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Cerus Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cerus Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Cerus Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cerus Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Cerus Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Cerus Corp, Medical Equipment, Deal Details 11
Partnerships 11
Cerus Enters into Agreement with Haemonetics 11
Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 11
Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 12
Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 13
Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 14
Cerus Enters Into Distribution Agreement With Ilex Biotech 15
Equity Offering 15
Cerus Plans to Raise USD70 Million in Public Offering of Shares 15
Cerus Prices Public Offering of Shares for USD70 Million 16
Cerus Completes Public Offering Of Shares For US$40.3 Million 17
Cerus Corp - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Mar 07, 2017: Cerus Reports Fourth Quarter and Year End 2016 Results 23
Nov 03, 2016: Cerus Reports Third Quarter 2016 Results 25
Aug 04, 2016: Cerus Reports Second Quarter 2016 Results 27
May 03, 2016: Cerus Corporation Reports First Quarter 2016 Results 29
Mar 08, 2016: Cerus Reports Fourth Quarter and Year End 2015 Results 30
Corporate Communications 32
Aug 09, 2016: Vivek Jayaraman Appointed as Cerus Corporation’s Chief Commercial Officer 32
Jan 11, 2016: Cerus Appoints New Leadership for Europe, Middle East and Africa Region 33
Product News 34
03/16/2016: Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma 34
03/15/2016: Cerus Announces the Inclusion of Pathogen Reduction Technology in FDA’s Revised Guidance Document on Bacterial Safety Standards for Platelets 35
03/09/2016: Blood Centers of America Selects Cerus as its Supply Partner for Pathogen Reduction Technology 36
02/09/2016: Cerus Enters Multi-Year Agreement with the American Red Cross for the Use of INTERCEPT Platelets and Plasma 37
01/14/2016: AABB Authorizes Use of the INTERCEPT Blood System for Platelets to Reduce the Risk of Transfusion-Associated Graft Versus Host Disease 38
01/05/2016: Cerus Announces Agreement with Blood Systems for the Use of INTERCEPT Platelets and Plasma 39
Product Approvals 40
Mar 16, 2016: Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma 40
Other Significant Developments 41
Oct 10, 2016: Cerus Announces that Hemolife Fundación Banco Nacional de Sangre Has Entered into Routine Use of the INTERCEPT Blood System 41
Jul 11, 2016: Cerus Provides an Update on Adoption by Blood Centers of America Members for the INTERCEPT Blood System for Platelets and Plasma 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Tables
Cerus Corp, Medical Equipment, Key Facts, 2015 1
Cerus Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Cerus Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cerus Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Cerus Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cerus Corp, Deals By Market, 2011 to YTD 2017 9
Cerus Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Cerus Enters into Agreement with Haemonetics 11
Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 11
Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 12
Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 13
Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 14
Cerus Enters Into Distribution Agreement With Ilex Biotech 15
Cerus Plans to Raise USD70 Million in Public Offering of Shares 15
Cerus Prices Public Offering of Shares for USD70 Million 16
Cerus Completes Public Offering Of Shares For US$40.3 Million 17
Cerus Corp, Key Competitors 20
Cerus Corp, Key Employees 21
Cerus Corp, Subsidiaries 22
List of Figures
Cerus Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Cerus Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Cerus Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Cerus Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Cerus Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cerus Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Cerus Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cerus Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
